[{"address1": "60 Binney Street", "city": "Cambridge", "state": "MA", "zip": "02142", "country": "United States", "phone": "617 675 7270", "website": "https://www.2seventybio.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company's products pipeline includes Abecma, a chimeric antigen receptor T-cell product candidates for the treatment of multiple myeloma. It has a collaboration arrangement with Bristol Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.", "fullTimeEmployees": 274, "companyOfficers": [{"maxAge": 1, "name": "Mr. William D. Baird III, M.B.A.", "age": 51, "title": "CEO, President & Director", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 708004, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Victoria  Eatwell", "age": 37, "title": "Chief Financial Officer", "yearBorn": 1986, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jessica  Snow", "age": 44, "title": "Senior VP of Quality and Head of Operations", "yearBorn": 1979, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Anna  Truppel-Hartmann", "title": "Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 10, "boardRisk": 8, "compensationRisk": 10, "shareHolderRightsRisk": 7, "overallRisk": 10, "governanceEpochDate": 1725148800, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 4.41, "open": 4.43, "dayLow": 4.33, "dayHigh": 4.505, "regularMarketPreviousClose": 4.41, "regularMarketOpen": 4.43, "regularMarketDayLow": 4.33, "regularMarketDayHigh": 4.505, "beta": 1.785, "forwardPE": -10.829268, "volume": 98938, "regularMarketVolume": 98938, "averageVolume": 440758, "averageVolume10days": 258500, "averageDailyVolume10Day": 258500, "bid": 4.44, "ask": 4.48, "bidSize": 200, "askSize": 200, "marketCap": 229947152, "fiftyTwoWeekLow": 1.535, "fiftyTwoWeekHigh": 6.4, "priceToSalesTrailing12Months": 5.2118573, "fiftyDayAverage": 4.3909, "twoHundredDayAverage": 4.304175, "currency": "USD", "enterpriseValue": 276627872, "floatShares": 49997278, "sharesOutstanding": 51497900, "sharesShort": 6397877, "sharesShortPriorMonth": 7285862, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.1242, "heldPercentInsiders": 0.040749997, "heldPercentInstitutions": 0.95857, "shortRatio": 17.12, "shortPercentOfFloat": 0.1504, "bookValue": 4.56, "priceToBook": 0.97368425, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -156254000, "trailingEps": -3.06, "forwardEps": -0.41, "enterpriseToRevenue": 6.27, "enterpriseToEbitda": -1.567, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "TSVT", "underlyingSymbol": "TSVT", "shortName": "2seventy bio, Inc.", "longName": "2seventy bio, Inc.", "firstTradeDateEpochUtc": 1635946200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "f4b7e673-d101-3831-ada5-26d60bd8a06b", "gmtOffSetMilliseconds": -14400000, "currentPrice": 4.44, "targetHighPrice": 25.0, "targetLowPrice": 2.0, "targetMeanPrice": 10.75, "targetMedianPrice": 8.0, "recommendationMean": 2.5, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 201872992, "totalCashPerShare": 3.92, "ebitda": -176560000, "totalDebt": 251395008, "quickRatio": 4.661, "currentRatio": 4.764, "totalRevenue": 44120000, "debtToEquity": 107.066, "revenuePerShare": 0.853, "returnOnAssets": -0.19015, "returnOnEquity": -0.51886004, "freeCashflow": -84921376, "operatingCashflow": -150126000, "revenueGrowth": -0.751, "operatingMargins": -2.2700999, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]